Literature DB >> 26449856

Immunohistochemical analysis of transporters related to clearance of amyloid-β peptides through blood-cerebrospinal fluid barrier in human brain.

Koichi Matsumoto1, Yoichi Chiba1, Ryuji Fujihara1,2, Hiroyuki Kubo3, Haruhiko Sakamoto1, Masaki Ueno4.   

Abstract

A large number of previous reports have focused on the transport of amyloid-β peptides through cerebral endothelial cells via the blood-brain barrier, while fewer reports have mentioned the transport through the choroid plexus epithelium via the blood-cerebrospinal fluid barrier. Concrete roles of these two pathways remain to be clarified. In this study, we immunohistochemically examined the expression of transporters/receptors that are supposed to be related to the clearance of amyloid-β peptides in the choroid plexus epithelium, the ventricular ependymal cells and the brain microvessels, using seven autopsied human brains. In the choroid plexus epithelium, immunoreactivity for low-density lipoprotein receptor (LDLR), LDLR-related protein 1 (LRP1), LRP2, formylpeptide receptor-like 1 (FPRL1), ATP-binding cassette (ABC) transporter-A1 (ABCA1), ABCC1 and ABCG4 was seen in 7 of 7 brains, while that for ABCB1, ABCG2, RAGE and CD36 was seen in 0-2 brains. In the ventricular ependymal cells, immunoreactivity for CD36, LDLR, LRP1, LRP2, FPRL1, ABCA1, ABCC1 and ABCG4 was seen in 6-7 brains, while that for ABCB1, ABCG2 and RAGE was seen in 0-1 brain. Immunoreactivity for insulin-degrading enzyme (IDE) was seen in three and four brains in the choroid plexus epithelium and the ventricular ependymal cells, respectively. In addition, immunoreactivity for LDLR, ABCB1 and ABCG2 was seen in over 40 % of the microvessels (all seven brains), and that for FPRL1, ABCA1, ABCC1 and RAGE was seen in over 5 % of the microvessels (4-6 brains), while that for CD36, IDE, LRP1, LRP2 and ABCG4 was seen in less than 5 % of the microvessels (0-2 brains). These findings may suggest that these multiple transporters/receptors and IDE expressed on the choroid plexus epithelium, ventricular ependymal cells and brain microvessels complementarily or cooperatively contribute to the clearance of amyloid-β peptides from the brain.

Entities:  

Keywords:  Amyloid-β; Choroid plexus; Ependymal cell; Transporter

Mesh:

Substances:

Year:  2015        PMID: 26449856     DOI: 10.1007/s00418-015-1366-7

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  105 in total

1.  Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide.

Authors:  S M Hammad; S Ranganathan; E Loukinova; W O Twal; W S Argraves
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

2.  LRP2 in ependymal cells regulates BMP signaling in the adult neurogenic niche.

Authors:  Chandresh R Gajera; Helena Emich; Oleg Lioubinski; Annabel Christ; Ruth Beckervordersandforth-Bonk; Kazuaki Yoshikawa; Sebastian Bachmann; Erik Ilsø Christensen; Magdalena Götz; Gerd Kempermann; Andrew S Peterson; Thomas E Willnow; Annette Hammes
Journal:  J Cell Sci       Date:  2010-05-11       Impact factor: 5.285

3.  Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice.

Authors:  Markus Krohn; Cathleen Lange; Jacqueline Hofrichter; Katja Scheffler; Jan Stenzel; Johannes Steffen; Toni Schumacher; Thomas Brüning; Anne-Sophie Plath; Franziska Alfen; Anke Schmidt; Felix Winter; Katja Rateitschak; Andreas Wree; Jörg Gsponer; Lary C Walker; Jens Pahnke
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

4.  Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages.

Authors:  H Yazawa; Z X Yu; Y Le; W Gong; V J Ferrans; J J Oppenheim; C C Li; J M Wang
Journal:  FASEB J       Date:  2001-11       Impact factor: 5.191

5.  The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice.

Authors:  John D Fryer; Ronald B Demattos; Lynn M McCormick; Mark A O'Dell; Michael L Spinner; Kelly R Bales; Steven M Paul; Patrick M Sullivan; Maia Parsadanian; Guojun Bu; David M Holtzman
Journal:  J Biol Chem       Date:  2005-05-11       Impact factor: 5.157

Review 6.  Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models.

Authors:  Martin C Herzig; William E Van Nostrand; Mathias Jucker
Journal:  Brain Pathol       Date:  2006-01       Impact factor: 6.508

7.  Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides.

Authors:  Milla Koistinaho; Suizhen Lin; Xin Wu; Michail Esterman; Deanna Koger; Jeffrey Hanson; Richard Higgs; Feng Liu; Seema Malkani; Kelly R Bales; Steven M Paul
Journal:  Nat Med       Date:  2004-06-13       Impact factor: 53.440

8.  ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE.

Authors:  Suzanne E Wahrle; Hong Jiang; Maia Parsadanian; Justin Legleiter; Xianlin Han; John D Fryer; Tomasz Kowalewski; David M Holtzman
Journal:  J Biol Chem       Date:  2004-07-21       Impact factor: 5.157

9.  Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces.

Authors:  Silvia Gazzin; Nathalie Strazielle; Charlotte Schmitt; Michelle Fevre-Montange; J Donald Ostrow; Claudio Tiribelli; Jean-François Ghersi-Egea
Journal:  J Comp Neurol       Date:  2008-10-10       Impact factor: 3.215

10.  PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice.

Authors:  Mitsugu Yamanaka; Taizo Ishikawa; Angelika Griep; Daisy Axt; Markus P Kummer; Michael T Heneka
Journal:  J Neurosci       Date:  2012-11-28       Impact factor: 6.167

View more
  18 in total

1.  Measurement of cerebral ABCC1 transport activity in wild-type and APP/PS1-21 mice with positron emission tomography.

Authors:  Viktoria Zoufal; Severin Mairinger; Markus Krohn; Thomas Wanek; Thomas Filip; Michael Sauberer; Johann Stanek; Claudia Kuntner; Jens Pahnke; Oliver Langer
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-13       Impact factor: 6.200

Review 2.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

Review 3.  Targeting choroid plexus epithelium as a novel therapeutic strategy for hydrocephalus.

Authors:  Yijian Yang; Jian He; Yuchang Wang; Chuansen Wang; Changwu Tan; Junbo Liao; Lei Tong; Gelei Xiao
Journal:  J Neuroinflammation       Date:  2022-06-17       Impact factor: 9.587

4.  Brain Distribution of Drugs: Brain Morphology, Delivery Routes, and Species Differences.

Authors:  Fanchon Bourasset; Sylvain Auvity; Robert G Thorne; Jean-Michel Scherrmann
Journal:  Handb Exp Pharmacol       Date:  2022

5.  Expression and function of Abcg4 in the mouse blood-brain barrier: role in restricting the brain entry of amyloid-β peptide.

Authors:  Agnès Dodacki; Matthew Wortman; Bruno Saubaméa; Stéphanie Chasseigneaux; Sophie Nicolic; Nathalie Prince; Murielle Lochus; Anne-Laure Raveu; Xavier Declèves; Jean-Michel Scherrmann; Shailendra B Patel; Fanchon Bourasset
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

6.  Vascular RAGE transports oxytocin into the brain to elicit its maternal bonding behaviour in mice.

Authors:  Yasuhiko Yamamoto; Mingkun Liang; Seiichi Munesue; Kisaburo Deguchi; Ai Harashima; Kazumi Furuhara; Teruko Yuhi; Jing Zhong; Shirin Akther; Hisanori Goto; Yuya Eguchi; Yasuko Kitao; Osamu Hori; Yoshitake Shiraishi; Noriyuki Ozaki; Yu Shimizu; Tomoya Kamide; Akifumi Yoshikawa; Yasuhiko Hayashi; Mitsutoshi Nakada; Olga Lopatina; Maria Gerasimenko; Yulia Komleva; Natalia Malinovskaya; Alla B Salmina; Masahide Asano; Katsuhiko Nishimori; Steven E Shoelson; Hiroshi Yamamoto; Haruhiro Higashida
Journal:  Commun Biol       Date:  2019-02-25

Review 7.  Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer's disease.

Authors:  Soheil Madadi; Heidi Schwarzenbach; Massoud Saidijam; Reza Mahjub; Meysam Soleimani
Journal:  Cell Biosci       Date:  2019-11-12       Impact factor: 7.133

8.  Effect of Linguizhugan decoction on neuroinflammation and expression disorder of the amyloid β‑related transporters RAGE and LRP‑1 in a rat model of Alzheimer's disease.

Authors:  Qianfeng Hu; Beibei Yu; Qinlei Chen; Yi Wang; Yun Ling; Songxian Sun; Yinlong Shi; Chunxiang Zhou
Journal:  Mol Med Rep       Date:  2017-11-06       Impact factor: 2.952

Review 9.  Potential Pathways for CNS Drug Delivery Across the Blood-Cerebrospinal Fluid Barrier.

Authors:  Nathalie Strazielle; Jean-François Ghersi-Egea
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 10.  Lipid droplets in the nervous system.

Authors:  Isha Ralhan; Chi-Lun Chang; Jennifer Lippincott-Schwartz; Maria S Ioannou
Journal:  J Cell Biol       Date:  2021-06-21       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.